$Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience$

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience

Bibliographic Details
Main Authors:	Jihye Park, Jae Hee Cheon, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim
Format:	Article
Language:	English
Published:	Korean Association for the Study of Intestinal Diseases 2018-04-01
Series:	Intestinal Research
Online Access:	http://www.irjournal.org/upload/pdf/ir-16-315.pdf

Similar Items

Development of a Novel Endoscopic Scoring System to Predict Relapse after Surgery in Intestinal Behçet’s Disease
by: Jung Won Park, et al.
Published: (2018-11-01)

C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet’s disease
by: Eun Ae Kang, et al.
Published: (2021-10-01)

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
by: Jihye Park, et al.
Published: (2017-07-01)

Prevalence and risk factors for gallstone and renal stone formation in patients with intestinal Behçet’s disease
by: Jaewon Song, et al.
Published: (2024-09-01)

Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: a multicenter observational study
by: Jihye Park, et al.
Published: (2023-08-01)

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease
by: Jihye Park, et al.
Published: (2018-11-01)

Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet’s disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin
by: Yong Eun Park, et al.
Published: (2021-01-01)

Primary surgery versus pharmacotherapy for newly diagnosed ileocecal Crohn’s disease: a hospital-based cohort study
by: Yehyun Park, et al.
Published: (2024-09-01)

Cancer Risk in Patients with Intestinal Behçet’s Disease: A Nationwide Population-Based Study
by: Minkyung Han, et al.
Published: (2018-07-01)

Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
by: Yong Il Lee, et al.
Published: (2021-03-01)

Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence.
by: Jihye Park, et al.
Published: (2018-01-01)

Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet’s disease
by: Jihye Park, et al.
Published: (2023-03-01)

Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease
by: Hyun Jung Lee, et al.
Published: (2017-07-01)

Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet’s disease from Crohn’s disease
by: Jihye Park, et al.
Published: (2021-05-01)

Esophageal Involvement of Behcet’s Disease
by: Jae Yong Park, et al.
Published: (2020-12-01)

Clinical characteristics and risk factors related to polyposis recurrence and advanced neoplasm development among patients with non-hereditary colorectal polyposis
by: Jihun Jang, et al.
Published: (2023-10-01)

Effectiveness and safety of adalimumab in patients with intestinal Behçet’s disease: a real-world prospective observational study in South Korea
by: Jongwook Yu, et al.
Published: (2023-12-01)

Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
by: Jongwook Yu, et al.
Published: (2021-11-01)

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)
by: Jae Hee Cheon, et al.
Published: (2023-09-01)

Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome
by: Jun Zou, et al.
Published: (2022-09-01)

Probe-based confocal laser endomicroscopy in the differential diagnosis of inflammatory bowel diseases: a case series
by: Jung Won Park, et al.
Published: (2018-10-01)

New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases
by: Jihye Park, et al.
Published: (2024-01-01)

Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
by: Jongwook Yu, et al.
Published: (2022-05-01)

Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement
by: Hye Kyung Hyun, et al.
Published: (2022-05-01)

Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer
by: Jung Won Park, et al.
Published: (2022-01-01)

Effects of Perianal Involvement on Clinical Outcomes in Crohn’s Disease over 10 Years
by: Jin Young Yoon, et al.
Published: (2018-05-01)

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet’s Disease
by: Mariko Kaji, et al.
Published: (2015-01-01)

Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment
by: Hye Kyung Hyun, et al.
Published: (2022-03-01)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
by: Jihye Park, et al.
Published: (2021-09-01)

The relationship between diverticulosis and colorectal neoplasia: A meta-analysis.
by: Hyun Jung Lee, et al.
Published: (2019-01-01)

Immunopathogenesis of Ocular Behçet’s Disease
by: Un Chul Park, et al.
Published: (2014-01-01)

Rebleeding Rate and Risk Factors for Rebleeding after Device-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study
by: Yuna Kim, et al.
Published: (2022-04-01)

Clinical Usefulness of Immune Profiling for Differential Diagnosis between Crohn’s Disease, Intestinal Tuberculosis, and Behcet’s Disease
by: Ji Won Yoo, et al.
Published: (2023-09-01)

Clinical Course of Patients with Intestinal Behçet’s Disease According to Consensus-Based Diagnostic Categories
by: Yu Young Joo, et al.
Published: (2022-09-01)

Successfully treated isolated renal artery pseudoaneurysm in a patient with Behçet's disease
by: Sihyung Park, et al.
Published: (2016-06-01)

Refractory brainstem encephalitis mimicking progressive cerebral infarction: infliximab and methotrexate as a salvage immunotherapy
by: Sung-Ho Ahn, et al.
Published: (2021-06-01)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
by: Jihye Park, et al.
Published: (2021-09-01)

Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
by: Jihye Park, et al.
Published: (2022-09-01)

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
by: Hui Won Jang, et al.
Published: (2016-10-01)

Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease
by: Sook Hee Chung, et al.
Published: (2016-07-01)